BioTech News
-
InventisBio closes $70M series C financing
BioTech | News | 0 Comment | 18 Mar, 2019
InventisBio Inc., a clinical stage biotech company, announced the closing of a $70 million USD Series C financing in January 2019. This round of investment was co-led by Advantech Capital a...Read more
-
IBM Research to use ML for detecting Alzheimer's
BioTech | News | 0 Comment | 15 Mar, 2019
A research team led by Dr Ben Goudey at IBM Research – Australia is using machine learning (ML) to identify a set of proteins in blood that can predict the concentration of ...Read more
-
HitGen, SPARC collaborate for drug discovery research
BioTech | News | 0 Comment | 14 Mar, 2019
China based biotech company HitGen Ltd. and Sun Pharma Advanced Research Company Ltd. (SPARC) has announced a research collaboration to identify novel small molecule leads for targets of in...Read more
-
Lance Goudzwaard appointed as Chief Commercial Officer of Generex Biotechnology
BioTech | News | 0 Comment | 13 Mar, 2019
Generex Biotechnology Corporation has announced the appointment of Lance Goudzwaard as the Chief Commercial Officer for NuGenerex Distribution Solutions (NDS), the company’s wholly-ow...Read more
-
Natera and BGI Genomics announce $50M partnership
BioTech | News | 0 Comment | 12 Mar, 2019
Natera, Inc. , a leader in cell-free DNA genetic testing, and BGI Genomics Co., Ltd., the largest cell-free DNA clinical testing laboratory in China have announced a&nb...Read more
-
Roche gets FDA’s accelerated approval to Tecentriq for TNBC
BioTech | News | 0 Comment | 11 Mar, 2019
Roche has announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Tecentriq® (atezolizumab) plus chemotherapy (Abraxane® [paclitaxel protein-bou...Read more
-
BioTech | News | 0 Comment | 11 Mar, 2019
Takeda Pharmaceutical Company Limited has announced results from the Phase 3b head-to-head VARSITY study which demonstrated that the gut-selective biologic vedolizumab (Entyvio) was superio...Read more
-
P&P biotech obtains US patent for its platform technology
BioTech | News | 0 Comment | 11 Mar, 2019
China-based high-tech firm P&P Biotech has been awarded a patent from the US for its hydrophilic, electro-spinning composite scaffold biomaterial and related methods and appli...Read more
-
Trinity Biotech announces Q4 and FY 2018 financial results
BioTech | News | 0 Comment | 08 Mar, 2019
Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets has announced results for the quarter ended December 3...Read more
-
SOM Biotech closes a financing round of 7M Euros
BioTech | News | 0 Comment | 08 Mar, 2019
SOM Biotech, a clinical-stage drug discovery and development company focused on repurposing drugs for orphan diseases of the Central Nervous System headquartered at the Parc Científi...Read more
-
FDA accepts Genentech's XOFLUZA for the treatment of Influenza
BioTech | News | 0 Comment | 06 Mar, 2019
Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for XOFLUZA (baloxavir marboxil...Read more
-
Procarta raises €1.5M funding to develop new antibiotics
BioTech | News | 0 Comment | 05 Mar, 2019
Procarta Biosystems, a biotech company has announced €1.5 million of new funding from the Novo Holdings REPAIR Impact Fund to support development of novel therapies to combat antimicro...Read more
-
Pressure BioSciences collaborates with The Steinbeis Centre
BioTech | News | 0 Comment | 05 Mar, 2019
Pressure BioSciences has announced a collaboration with The Steinbeis Centre for Biopolymer Analysis & Biomedical Mass Spectrometry, a world-renowned German research organization. ...Read more
-
3SBio, TLC to commercialize two NanoX products in Mainland China
BioTech | News | 0 Comment | 04 Mar, 2019
3SBio Inc. and Taiwan Liposome Company, Ltd. (TLC) have announced an exclusive partnership to commercialize in mainland China two liposomal products utilizing TLC's proprietary NanoX™...Read more
-
Israel Innovation Authority approves NIS 13.6M for Kadimastem
BioTech | News | 0 Comment | 04 Mar, 2019
An Israeli biotechnology company Kadimastem announces that it has received approval for its annual budget from the Israel Innovation Authority, in the amount of NIS 13.6M, for its cell ther...Read more
-
Kadimastem completes cell transplantation of AstroRx in ALS patients
BioTech | News | 0 Comment | 01 Mar, 2019
Israeli biotechnology company Kadimastem has announced the completion of cell transplantation (AstroRx®) in 5 patients who were enrolled in Cohort A for its clinical trial in ALS. In p...Read more
-
Rakuten Aspyrian changes name to Rakuten Medical
BioTech | News | 0 Comment | 01 Mar, 2019
Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, announced that it has changed its name to Raku...Read more
-
Abpro, NJCTTQ to develop multiple novel bispecific antibodies
BioTech | News | 0 Comment | 01 Mar, 2019
Abpro, a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases, and NJCTTQ, a global...Read more
